The diagnosis of hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B indicating
therapeutic intervention currently requires serum hepatitis B virus (HBV) DNA ≥2,000 IU/mL. We …

Purpose The assessment of the level of anxiety, depression and quality of life among
patients with heart failure. Methods It was an observational study. The populations were 231 …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. To date, systemic treatment for patients with unresectable or advanced disease was …

Background and Aims: Thyroid dysfunction (TD) represents an extrahepatic manifestation of
chronic hepatitis C (CHC). Moreover, the currently approved treatment of CHC is often …

Objective To evaluate the diagnostic value of serum procalcitonin levels in patients with acute
or chronic liver disease, with or without bacterial infections and to correlate the results with …

Background Bloodstream Infections (BSIs) in neutropenic patients often cause considerable
morbidity and mortality. Therefore, the surveillance and early identification of patients at …

Objective Tamoxifen induced hepatotoxicity has not been investigated in breast cancer
patients with pre-existing liver steatosis. The aim of our study was to investigate the most …

Context Quizalofop-p-ethyl is an often applied, slightly toxic herbicide for which no severe
toxicity has been reported in humans. Case presentation We present the case of a farmer …

Objectives Data in the literature regarding the role of endoscopic variceal ligation for the
prevention of first variceal bleeding in cirrhotic patients are controversial. To further explore this …

A 32-year-old man with chronic hepatitis B who was treated with pegylated interferon alpha-2b
once a week, developed widespread psoriasis 4 weeks after the beginning of the …